Adovate
Biopharmaceutical company developing drug candidates that target adenosine receptors. Uses a next-generation adenosine drug discovery platform to design patented small-molecule compounds with optimized physicochemical properties and distribution kinetics to enable target-tissue delivery.
Industries
biotechnology
pharmaceutical
test-and-measurement
Nr. of Employees
small (1-50)
Products
Adenosine receptor-targeted drug candidates
Discovery-stage small-molecule therapeutic candidates designed to target adenosine receptors with optimized physicochemical properties and distribution kinetics to enhance tissue exposure.
Adenosine receptor-targeted drug candidates
Discovery-stage small-molecule therapeutic candidates designed to target adenosine receptors with optimized physicochemical properties and distribution kinetics to enhance tissue exposure.
Expertise Areas
- Adenosine receptor drug discovery
- Small-molecule medicinal chemistry
- Physicochemical property optimization
- Pharmacokinetics and biodistribution optimization
Key Technologies
- Adenosine receptor targeting
- Small-molecule design
- Physicochemical property optimization
- Pharmacokinetic/biodistribution profiling